{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:04:48Z","timestamp":1791389088452,"version":"4.3.3"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cld.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:50:31Z","timestamp":1537905031000},"page":"689-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Autoimmune Hepatitis, Sclerosing Cholangitis, and\u00a0Autoimmune Sclerosing\u00a0Cholangitis or Overlap\u00a0Syndrome"],"prefix":"10.1016","volume":"22","author":[{"given":"Nanda","family":"Kerkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2018.06.005_bib2","doi-asserted-by":"crossref","unstructured":"Kerkar N, Mack CL, Autoimmune Hepatitis. In: Suchy FJ, Sokol RJ, Balistreri WF, editors. Liver disease in children. 4th edition. Cambridge (UK): Cambridge University Press. p. 311\u201321.","DOI":"10.1017\/CBO9781139012102.021"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with drug-induced liver injury","volume":"15","author":"de Boer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrgastro.2011.69","article-title":"Autoimmune hepatitis","volume":"8","author":"Mieli-Vergani","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J\u00a0Autoimmun"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2009.08.010","article-title":"Aetiopathogenesis of autoimmune hepatitis","volume":"34","author":"Longhi","year":"2010","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.cld.2018.06.005_bib9","first-page":"113","article-title":"Liver, blood proteins and nutritive protein","volume":"9","author":"Waldenstrom","year":"1953","journal-title":"Dtsch Z Verdau Stoffwechselkr"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.1840180435","article-title":"Meeting report: international autoimmune hepatitis group","volume":"18","author":"Johnson","year":"1993","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib11","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib13","first-page":"391","article-title":"Azathioprine metabolite measurements in the treatment of autoimmune hepatitis in pediatric patients: a preliminary report","volume":"35","author":"Rumbo","year":"2002","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib14","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPG.0b013e3181d29750","article-title":"Allopurinol salvage therapy in pediatric overlap autoimmune hepatitis-primary sclerosing cholangitis with 6-MMP toxicity","volume":"51","author":"Dunkin","year":"2010","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib15","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jhep.2010.09.017","article-title":"Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment","volume":"54","author":"Lohse","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib19","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2012.11.010","article-title":"Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis","volume":"58","author":"Weiler-Normann","year":"2013","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib21","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MPG.0000000000001759","article-title":"Anti-TNFalpha treatment in children and adolescents with combined inflammatory bowel disease and autoimmune liver disease","volume":"66","author":"Nedelkopoulou","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.cld.2018.06.005_bib22","article-title":"New onset autoimmune hepatitis during anti-tumor necrosis factor-alpha treatment in children","author":"Ricciuto","year":"2017","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4254\/wjh.v9.i1.57","article-title":"Clinical usefulness of ursodeoxycholic acid for Japanese patients with autoimmune hepatitis","volume":"9","author":"Torisu","year":"2017","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2018.06.005_bib24","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.dld.2017.05.026","article-title":"Successful management of acute liver failure in Italian children: a 16-year experience at a referral centre for paediatric liver transplantation","volume":"49","author":"Di Giorgio","year":"2017","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7869\/tg.160","article-title":"Clinicopathological profile and management of severe autoimmune hepatitis","volume":"35","author":"Ramachandran","year":"2014","journal-title":"Trop Gastroenterol"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","author":"Molmenti","year":"2002","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A\u00a010 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"issue":"9100","key":"10.1016\/j.cld.2018.06.005_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2018.06.005_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","article-title":"'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: a comprehensive review","volume":"66","author":"Kerkar","year":"2016","journal-title":"J\u00a0Autoimmun"},{"issue":"10","key":"10.1016\/j.cld.2018.06.005_bib30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2010.01.002","article-title":"Autoimmune hepatitis in children\u2013impact of cirrhosis at presentation on natural history and long-term outcome","volume":"42","author":"Radhakrishnan","year":"2010","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MOG.0b013e3283388f5b","article-title":"Unique features of primary sclerosing cholangitis in children","volume":"26","author":"Mieli-Vergani","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib32","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/s0004-2803.201700000-50","article-title":"Primary sclerosing cholangitis in children and adolescents","volume":"54","author":"Fagundes","year":"2017","journal-title":"Arq Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cgh.2008.10.019","article-title":"A\u00a0retrospective single-center review of primary sclerosing cholangitis in children","volume":"7","author":"Miloh","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau","year":"2017","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S1499-3872(16)60088-7","article-title":"Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis","volume":"15","author":"Smolka","year":"2016","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/2050640615616012","article-title":"Clinical course and prognosis of pediatric-onset primary sclerosing cholangitis","volume":"4","author":"Tenca","year":"2016","journal-title":"United European Gastroenterol J"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPG.0000000000001492","article-title":"Hepatic issues and complications associated with inflammatory bowel disease: a clinical report from the NASPGHAN inflammatory bowel disease and hepatology committees","volume":"64","author":"Saubermann","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib40","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MPG.0b013e31815a98ef","article-title":"Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis","volume":"46","author":"Lindberg","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib41","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/MPG.0b013e31825bb3dc","article-title":"Investigative MRI cholangiopancreatography for primary sclerosing cholangitis-type lesions in children with IBD","volume":"55","author":"Alexopoulou","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib42","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MPG.0000000000001531","article-title":"Unique inflammatory bowel disease phenotype of pediatric primary sclerosing cholangitis: a single-center study","volume":"65","author":"Shiau","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib43","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"issue":"9904","key":"10.1016\/j.cld.2018.06.005_bib44","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/MPG.0000000000001368","article-title":"The natural history of primary sclerosing cholangitis in children: a large single-center longitudinal cohort study","volume":"63","author":"Valentino","year":"2016","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib46","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11894-010-0104-5","article-title":"Sclerosing cholangitis: pediatric perspective","volume":"12","author":"Kerkar","year":"2010","journal-title":"Curr Gastroenterol Rep"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib48","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/MPG.0000000000001438","article-title":"Liver transplantation for children with primary sclerosing cholangitis and autoimmune hepatitis: unos database analysis","volume":"64","author":"Jossen","year":"2017","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib49","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4254\/wjh.v7.i5.799","article-title":"Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist","volume":"7","author":"Modha","year":"2015","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib50","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2559.2011.03853.x","article-title":"Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation","volume":"60","author":"Portmann","year":"2012","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib51","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.06.005_bib52","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/hep.21405","article-title":"Sclerosing cholangitis: a focus on secondary causes","volume":"44","author":"Abdalian","year":"2006","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.cld.2018.06.005_bib53","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/j.1872-034X.2009.00527.x","article-title":"Ursodeoxycholic acid in primary sclerosing cholangitis: meta-analysis of randomized controlled trials","volume":"39","author":"Shi","year":"2009","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib54","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib55","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/hep.27074","article-title":"Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis","volume":"60","author":"Wunsch","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib57","first-page":"e65","article-title":"Rapid development of secondary sclerosing cholangitis due to vancomycin-resistant enterococci","volume":"54","author":"Hoffmeister","year":"2007","journal-title":"J\u00a0Infect"},{"issue":"8","key":"10.1016\/j.cld.2018.06.005_bib58","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/lt.22320","article-title":"Pediatric liver transplantation for primary sclerosing cholangitis","volume":"17","author":"Miloh","year":"2011","journal-title":"Liver Transpl"},{"issue":"6","key":"10.1016\/j.cld.2018.06.005_bib59","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"19","author":"Bjornsson","year":"1999","journal-title":"Liver"},{"issue":"1","key":"10.1016\/j.cld.2018.06.005_bib60","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouilleres","year":"1990","journal-title":"J\u00a0Hepatol"},{"issue":"3","key":"10.1016\/j.cld.2018.06.005_bib61","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2018.06.005_bib62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MPG.0000000000001783","article-title":"Autoimmune hepatitis and autoimmune hepatitis overlap with sclerosing cholangitis: immunophenotype markers in children and adolescents","volume":"66","author":"Ferri","year":"2018","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2018.06.005_bib63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000440830","article-title":"IgG4-associated cholangitis\u2013a mimic of PSC","volume":"33","author":"Beuers","year":"2015","journal-title":"Dig Dis"},{"issue":"4","key":"10.1016\/j.cld.2018.06.005_bib64","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cld.2011.08.008","article-title":"Recurrent and de novo autoimmune liver diseases","volume":"15","author":"Mendes","year":"2011","journal-title":"Clin Liver Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:55:16Z","timestamp":1761069316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1089326118300564"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.06.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune Hepatitis, Sclerosing Cholangitis, and\u00a0Autoimmune Sclerosing\u00a0Cholangitis or Overlap\u00a0Syndrome","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}